The topic of sustainability continues to grow as pharmaceutical companies dig deeper into their supply chains to better understand their true impact on the environment. Yet, according to a recent article in Applied Clinical Trials, these conversations focus primarily on the commercial supply chain and do not provide a fair assessment of the clinical supply chain.
Though packaging used to move medication from depots to clinical sites are now reusable and offer a more eco-friendly option for transport, there’s still an opportunity to refine how pharmaceutical companies safely and efficiently deliver drugs to patients. According to the article’s author, this includes innovation in forecasting, measurement tools, ancillary waste and drug transportation. These become even more important as clinical trials progress and enroll more participants.
To learn more about ways to evaluate sustainability for clinical trials, view the full article on Applied Clinical Trials’ website.